
Ashok Patel
Examiner (ID: 15502, Phone: (571)272-2456 , Office: P/2879 )
| Most Active Art Unit | 2875 |
| Art Unit(s) | 2889, 2879, 2618, 2215, 2875, 2604 |
| Total Applications | 2975 |
| Issued Applications | 2581 |
| Pending Applications | 71 |
| Abandoned Applications | 334 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19140342
[patent_doc_number] => 20240139119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => DICLOFENAC-CONTAINING PATCH PACKAGE PRODUCT AND METHOD FOR STABILIZING DICLOFENAC SODIUM
[patent_app_type] => utility
[patent_app_number] => 18/278279
[patent_app_country] => US
[patent_app_date] => 2022-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6503
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18278279
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/278279 | DICLOFENAC-CONTAINING PATCH PACKAGE PRODUCT AND METHOD FOR STABILIZING DICLOFENAC SODIUM | Feb 17, 2022 | Pending |
Array
(
[id] => 17640618
[patent_doc_number] => 20220168356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-02
[patent_title] => ALLOGRAFTS CONTAINING VIABLE CELLS AND METHODS THEROF
[patent_app_type] => utility
[patent_app_number] => 17/672983
[patent_app_country] => US
[patent_app_date] => 2022-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6096
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17672983
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/672983 | ALLOGRAFTS CONTAINING VIABLE CELLS AND METHODS THEROF | Feb 15, 2022 | Abandoned |
Array
(
[id] => 20271846
[patent_doc_number] => 12441615
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Method of administering nitric oxide gas
[patent_app_type] => utility
[patent_app_number] => 17/670383
[patent_app_country] => US
[patent_app_date] => 2022-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6687
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17670383
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/670383 | Method of administering nitric oxide gas | Feb 10, 2022 | Issued |
Array
(
[id] => 18852708
[patent_doc_number] => 11850260
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-26
[patent_title] => Medicinal nanocomposite and method of preparation thereof
[patent_app_type] => utility
[patent_app_number] => 17/665014
[patent_app_country] => US
[patent_app_date] => 2022-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 50
[patent_no_of_words] => 14863
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17665014
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/665014 | Medicinal nanocomposite and method of preparation thereof | Feb 3, 2022 | Issued |
Array
(
[id] => 17790649
[patent_doc_number] => 20220249740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => BIOMIMETIC TISSUE AND METHOD OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/592169
[patent_app_country] => US
[patent_app_date] => 2022-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18521
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17592169
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/592169 | BIOMIMETIC TISSUE AND METHOD OF USE THEREOF | Feb 2, 2022 | Pending |
Array
(
[id] => 17593340
[patent_doc_number] => 20220142913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => TRANSDERMAL DELIVERY FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/585170
[patent_app_country] => US
[patent_app_date] => 2022-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17585170
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/585170 | TRANSDERMAL DELIVERY FORMULATIONS | Jan 25, 2022 | Abandoned |
Array
(
[id] => 19081782
[patent_doc_number] => 20240108583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-04
[patent_title] => NALTREXONE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/273710
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7151
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273710
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/273710 | NALTREXONE COMPOSITIONS | Jan 24, 2022 | Pending |
Array
(
[id] => 19629836
[patent_doc_number] => 20240408285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => IMPLANTABLE MATERIAL IN CONTACT WITH BLOOD AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/273990
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273990
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/273990 | IMPLANTABLE MATERIAL IN CONTACT WITH BLOOD AND USES THEREOF | Jan 23, 2022 | Pending |
Array
(
[id] => 19431080
[patent_doc_number] => 20240299578
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => An Oral Insulin Delivery Salt Nano-Precipitate
[patent_app_type] => utility
[patent_app_number] => 18/546142
[patent_app_country] => US
[patent_app_date] => 2022-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18546142
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/546142 | An Oral Insulin Delivery Salt Nano-Precipitate | Jan 23, 2022 | Pending |
Array
(
[id] => 18027734
[patent_doc_number] => 11510893
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-11-29
[patent_title] => Methocarbamol composition and related methods
[patent_app_type] => utility
[patent_app_number] => 17/579278
[patent_app_country] => US
[patent_app_date] => 2022-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14394
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17579278
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/579278 | Methocarbamol composition and related methods | Jan 18, 2022 | Issued |
Array
(
[id] => 19049438
[patent_doc_number] => 20240091407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => CARTILAGE TISSUE ENGINEERING COMPLEX AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/262232
[patent_app_country] => US
[patent_app_date] => 2022-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6488
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18262232
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/262232 | CARTILAGE TISSUE ENGINEERING COMPLEX AND USE THEREOF | Jan 16, 2022 | Pending |
Array
(
[id] => 19232154
[patent_doc_number] => 20240189345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-13
[patent_title] => INTESTINAL BACTERIA REDUCING AGENT
[patent_app_type] => utility
[patent_app_number] => 18/550844
[patent_app_country] => US
[patent_app_date] => 2022-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18550844
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/550844 | INTESTINAL BACTERIA REDUCING AGENT | Jan 16, 2022 | Abandoned |
Array
(
[id] => 17577214
[patent_doc_number] => 20220134069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => DEVICE POSITIONABLE IN THE UTERINE CAVITY AND METHOD OF TREATMENT THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/575767
[patent_app_country] => US
[patent_app_date] => 2022-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7811
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17575767
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/575767 | Device positionable in the uterine cavity and method of treatment thereof | Jan 13, 2022 | Issued |
Array
(
[id] => 17952375
[patent_doc_number] => 11478447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Solid D
[patent_app_type] => utility
[patent_app_number] => 17/575035
[patent_app_country] => US
[patent_app_date] => 2022-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 41
[patent_no_of_words] => 9637
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17575035
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/575035 | Solid D | Jan 12, 2022 | Issued |
Array
(
[id] => 17733115
[patent_doc_number] => 20220218574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => COSMETIC COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/647877
[patent_app_country] => US
[patent_app_date] => 2022-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16160
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17647877
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/647877 | Cosmetic compositions | Jan 12, 2022 | Issued |
Array
(
[id] => 19032344
[patent_doc_number] => 20240082159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => METHOD FOR PREPARING PROTEIN MICROBEADS FOR IMPROVING STABILITY OF PROTEIN PREPARATION
[patent_app_type] => utility
[patent_app_number] => 18/263420
[patent_app_country] => US
[patent_app_date] => 2021-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18263420
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/263420 | METHOD FOR PREPARING PROTEIN MICROBEADS FOR IMPROVING STABILITY OF PROTEIN PREPARATION | Dec 29, 2021 | Pending |
Array
(
[id] => 17648449
[patent_doc_number] => 11351148
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-06-07
[patent_title] => Pharmaceutical composition Mix A to treat health conditions associated with elevated glucose levels
[patent_app_type] => utility
[patent_app_number] => 17/563944
[patent_app_country] => US
[patent_app_date] => 2021-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5716
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17563944
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/563944 | Pharmaceutical composition Mix A to treat health conditions associated with elevated glucose levels | Dec 27, 2021 | Issued |
Array
(
[id] => 19011753
[patent_doc_number] => 11918654
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Solid solution compositions and use in severe pain
[patent_app_type] => utility
[patent_app_number] => 17/646241
[patent_app_country] => US
[patent_app_date] => 2021-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 58965
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17646241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/646241 | Solid solution compositions and use in severe pain | Dec 27, 2021 | Issued |
Array
(
[id] => 17618933
[patent_doc_number] => 11337959
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-05-24
[patent_title] => Pharmaceutical composition Mix B to treat health conditions associated with elevated glucose levels
[patent_app_type] => utility
[patent_app_number] => 17/561971
[patent_app_country] => US
[patent_app_date] => 2021-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 5412
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17561971
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/561971 | Pharmaceutical composition Mix B to treat health conditions associated with elevated glucose levels | Dec 25, 2021 | Issued |
Array
(
[id] => 18970288
[patent_doc_number] => 20240050380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-15
[patent_title] => IMPROVED PATCH
[patent_app_type] => utility
[patent_app_number] => 18/258297
[patent_app_country] => US
[patent_app_date] => 2021-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4554
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258297
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/258297 | IMPROVED PATCH | Dec 21, 2021 | Pending |